Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: The role of 18F-FDG PET/MRI in assessing pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis

Fig. 3

Forest plots showing the pooled estimate of sensitivity (a) and specificity (b) of MRI in Assessing pCR to NAC in patients with breast cancer, The square represents the effect estimate of individual studies with more than 95% confidence intervals (95% CI), with the size of squares proportional to the weight assigned to the study in the meta-analysis. Diamond denotes the overall estimation

Back to article page